Christopher E. Barbieri, Ph.D.
Affiliations: | 2005 | Vanderbilt University, Nashville, TN |
Area:
Cell BiologyGoogle:
"Christopher Barbieri"Parents
Sign in to add mentorJennifer A. Pietenpol | grad student | 2005 | Vanderbilt | |
(The role of p63 in the development, maintenance, and tumorigenesis of squamous epithelium.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Augello MA, Chen X, Liu D, et al. (2024) Canonical AREs are tumor suppressive regulatory elements in the prostate. Biorxiv : the Preprint Server For Biology |
Pakula H, Omar M, Carelli R, et al. (2024) Distinct mesenchymal cell states mediate prostate cancer progression. Nature Communications. 15: 363 |
Benedetti E, Chetnik K, Flynn T, et al. (2023) Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort. Scientific Data. 10: 830 |
Qureshy SA, Diven MA, Ma X, et al. (2023) Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer. Jama Network Open. 6: e2337165 |
Geng C, Zhang MC, Manyam GC, et al. (2023) SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Arenas-Gallo C, Rhodes S, Garcia JA, et al. (2023) Prostate cancer genetic alterations in Hispanic men. The Prostate |
Pakula H, Omar M, Carelli R, et al. (2023) Distinct mesenchymal cell states mediate prostate cancer progression. Biorxiv : the Preprint Server For Biology |
Jeon HY, Pornour M, Ryu H, et al. (2023) SMAD3 promotes expression and activity of the androgen receptor in prostate cancer. Nucleic Acids Research |
Brady NJ, Barbieri CE. (2022) JAK inhibition shows two faces in prostate cancer. Nature Cancer. 3: 1021-1023 |
Arenas-Gallo C, Owiredu J, Weinstein I, et al. (2022) Race and prostate cancer: genomic landscape. Nature Reviews. Urology. 19: 547-561 |